- Joined
- Aug 5, 2005
- Messages
- 3,858
- Reaction score
- 1,630
Fixed it! 🤣🤣🤣
Except you didn’t
Fixed it! 🤣🤣🤣
Wrong though- lumpectomy + AI without RT has a recurrence rate greater than lumpectomy + RT and greater than 3%.
View attachment 378352
Of 740 registered patients, 500 eligible patients were enrolled.
At 5 years after enrollment, recurrence was reported in 2.3% of the patients (90% confidence interval [CI], 1.3 to 3.8; 95% CI, 1.2 to 4.1).
I know, I know. It's only 5 years. But that's what the med. oncs read.
In 50 years, the significant push to omit a brief course of radiation therapy in favor of destroying a woman's endocrine system for five years will be considered antiquated barbarism."If we put all men on ADT for prostate cancer for 5 years after surgery we'd see very few recurrences as well, but I guess women's sexual health doesn't matter like men's" - my favorite comment on here last time this was discussed.
I completely agree with you."If we put all men on ADT for prostate cancer for 5 years after surgery we'd see very few recurrences as well, but I guess women's sexual health doesn't matter like men's" - my favorite comment on here last time this was discussed.
that is the heart of the issue. Great to see that Fei Fei Liu- (chair of SCAROP who wrote letter to medical school deans criticizing sdn for impact on residency applicants) is a much deserved co author.I completely agree with you.
I was merely making the point that local recurrence of breast cancer in well selected patient populations can be very low (<5%), even without RT.
Or in other words, it’s beginning to look a lot like prostate…As an aside ER positive breast cancer is weird. The number of late distant recurrences in T1N0 disease is surprisingly high. Five years may not be the ideal time point for this disease
I'm always reminded of this https://ascopubs.org/doi/10.1200/JCO.2003.02.009?url_ver=Z39.88-2003As an aside ER positive breast cancer is weird. The number of late distant recurrences in T1N0 disease is surprisingly high. Five years may not be the ideal time point for this disease
As an aside ER positive breast cancer is weird. The number of late distant recurrences in T1N0 disease is surprisingly high. Five years may not be the ideal time point for this disease
Or in other words, it’s beginning to look a lot like prostate…
Wild anecdote ahead, read at your own risk:I'm always reminded of this https://ascopubs.org/doi/10.1200/JCO.2003.02.009?url_ver=Z39.88-2003
Is this an argument against the “just do apbi instead of the AI!”?Wild anecdote ahead, read at your own risk:
Like clockwork, 1-2 times per quarter per year I will be referred a newly diagnosed metastatic breast cancer patient. Almost always endocrine receptor positive, almost always the same histology as her original localized disease...
And her original localized disease was 15-20 years ago.
This was an epiphany I had when I realized I wasn't reacting the same way as the staff member presenting the patient to me. Because it's 2-3 months in between cases, it's basically never the same RN/MA/secretary etc consecutively giving me the patient.
The staff member would be flabbergasted. I would not be flabbergasted. As my reaction grew consistently distant from theirs, I couldn't stop noticing it.
I dunno. Probably several biases and confounders happening. But I don't see any other diseases like this.
Maybe?Is this an argument against the “just do apbi instead of the AI!”?
Most other patients are dead by then. Even early NSCLC has a bad prognosis at 10 years, if you look at the graphs.But I don't see any other diseases like this.
Renal cellWild anecdote ahead, read at your own risk:
Like clockwork, 1-2 times per quarter per year I will be referred a newly diagnosed metastatic breast cancer patient. Almost always endocrine receptor positive, almost always the same histology as her original localized disease...
And her original localized disease was 15-20 years ago.
This was an epiphany I had when I realized I wasn't reacting the same way as the staff member presenting the patient to me. Because it's 2-3 months in between cases, it's basically never the same RN/MA/secretary etc consecutively giving me the patient.
The staff member would be flabbergasted. I would not be flabbergasted. As my reaction grew consistently distant from theirs, I couldn't stop noticing it.
I dunno. Probably several biases and confounders happening. But I don't see any other diseases like this.
Yeah this was where my brain took me as well, the last time I really thought about it.Most other patients are dead by then. Even early NSCLC has a bad prognosis at 10 years, if you look at the graphs.
Prostate cancer patients are different, because they are a) either dead 15-20 years after primary diagnosis because of age and b) they get PSA follow ups and metastatic recurrence is picked up rather early.
Breast is different. The long duration of AI adjuvant therapy likely also changes the way or let's say "velocity" the disease comes back.
We’d convert one in four stage I patients into stage IV if we did bone marrow biopsy as routine staging work upWild anecdote ahead, read at your own risk:
Like clockwork, 1-2 times per quarter per year I will be referred a newly diagnosed metastatic breast cancer patient. Almost always endocrine receptor positive, almost always the same histology as her original localized disease...
And her original localized disease was 15-20 years ago.
This was an epiphany I had when I realized I wasn't reacting the same way as the staff member presenting the patient to me. Because it's 2-3 months in between cases, it's basically never the same RN/MA/secretary etc consecutively giving me the patient.
The staff member would be flabbergasted. I would not be flabbergasted. As my reaction grew consistently distant from theirs, I couldn't stop noticing it.
I dunno. Probably several biases and confounders happening. But I don't see any other diseases like this.
We’d convert one in four stage I patients into stage IV if we did bone marrow biopsy as routine staging work up
I wonder how many random women we'd convert into stage IV breast cancer with random bone Marrow biopsy.We’d convert one in four stage I patients into stage IV if we did bone marrow biopsy as routine staging work up
And there’s a lot of “stage I” breast in America
We’d convert one in four stage I patients into stage IV if we did bone marrow biopsy as routine staging work up
And there’s a lot of “stage I” breast in America
Recent paper re ITC in bone marrow changes the game.. But who will be doing BMbx on their next patient w stage I coming into the office?do you have a reference for this?
do you have a reference for this?
Monica Morrow said rad oncs are "obsessed" with local control in breast cancer. I don't know if full-on silly. Probably a continuum between silly and non-silly:Thanks. Really makes the local therapy debates kind of silly huh. Or makes you really wonder about getting rid of AI in this population, as is being investigated (which I’m still supportive of the trials as the older patients probably won’t live long enough to met out, probably?)
How many stage 1-3 breast cancer patients has morrow not operated on? Surgery is also locoregional control .Monica Morrow said rad oncs are "obsessed" with local control in breast cancer. I don't know if full-on silly. Probably a continuum between silly and non-silly:
“Variations in local-regional therapy are unlikely to substantially affect survival... when a patient is diagnosed with breast cancer, every effort must be made to control locoregional disease to prevent further tumor cell dissemination. And, to do so does matter. However, tumor and host factors that are in play before the diagnosis and treatment of cancer are of primary importance with regard to determining survival."
IOW, she's saying that in general rad oncs aren't lying to their patients.How many stage 1-3 breast cancer patients has morrow not operated on? Surgery is also locoregional control .
I'm sorry to keep beating this drum, but it's frustrating to see people being so nihilistic about radiation.
Radiotherapy improves overall survival in glioblastoma.
It almost certainly improves survival for lower grade gliomas as well. Sure there was non-believers trial which didn't show OS to early radiation, but they all got radiation eventually...
Agree that there have been a lot of failed attempts to improve upon radiation, but same can be said for systemic therapies. For example, immunotherapy actually worsened survival in glioblastoma.
Brain cancers are bad diseases that radiation has a central role in.
You see any surgeons sitting around talking about how there are no randomized trials showing improved OS for surgery in glioma?
In her defense, in the link cited she said "surgeons and radoncs are obsessed" not just radoncs. I would be willing to guess the patients are also somewhat "obsessed" with locoregional control, so I really disagree with her sentiment here.How many stage 1-3 breast cancer patients has morrow not operated on? Surgery is also locoregional control .
It’s interesting to ponder that Europa could lead to a come back of RT in older patients because they don’t live long enough to enjoy the benefits of AI, but RT could be omitted in the 50-60 year olds because it has a minimal LC improvement but also doesn’t affect distant Mets the way AI does.Or makes you really wonder about getting rid of AI in this population, as is being investigated (which I’m still supportive of the trials as the older patients probably won’t live long enough to met out, probably?)
I took it to mean that there has not been anything new regarding RT role in improving the outcomes in gliomas in a long time.
![]()
The only thing we have managed to do is cut down the numbers of fractions necessary in elderly/frail patients and proved that it's safe to do so, even when combined with systemic treatment. That's it.
Outside of TTF, the answer to GBM hasn't been anything. Including nearly every systemic therapy under the sun. Unless folks are doing concurrent Lomustine...We tried an SRS boost and the Japanese took half of the brain to 90 Gy before they ran into toxicity- neither showed any benefit. I feel pretty confident when I say that we've tried more or less everything we could for GBM. The answer for GBM isn't going to be radiation.
I have a better avenue! Still have to try it!Outside of TTF, the answer to GBM hasn't been anything. Including nearly every systemic therapy under the sun. Unless folks are doing concurrent Lomustine...
Maybe one day rad onc as a field will really search their technologically biased souls on this![]()
The only thing we have managed to do is cut down the numbers of fractions necessary in elderly/frail patients and proved that it's safe to do so, even when combined with systemic treatment. That's it.
I've already written off UK, Canadian and American radiation oncology.
Good thing you took a screenshot because that post has already been deleted.
I've already written off UK, Canadian and American radiation oncology.
Germany is indeed the last hope in terms of both absence of fraction shaming for breast cancer and promoting healing rays for arthritis.
and dei![]()
Fraction/Volume shaming...
-ASTRO